Lack of Relationship Between Microvascular and Macrovascular Disease in Heart Transplant Recipients

被引:15
作者
Abu-Qaoud, Mohamed S. [1 ]
Stoletniy, Liset N. [1 ]
Chen, David [1 ]
Kerstetter, Justin [1 ]
Kuhn, Michael [1 ]
Pai, Ramdas G. [1 ]
机构
[1] Loma Linda Univ, Med Ctr, Heart & Imaging Ctr, Loma Linda, CA 92354 USA
关键词
Heart transplant; Microangiopathy; Macrosvascular disease; CARDIAC ALLOGRAFT VASCULOPATHY; INTRACORONARY ULTRASOUND; CYCLOSPORINE; TACROLIMUS; SURVIVAL; IMPACT; FK506;
D O I
10.1097/TP.0b013e31826accca
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A key determinant of long-term survival in heart transplant recipients is the development of coronary vasculopathy. Both coronary macrovascular and microvascular disease are prognostically important. However, the relationship between these in transplant patients and the determinants of microvascular disease are not known. Methods. We reviewed the simultaneously obtained endomyocardial biopsies and intravascular ultrasound (IVUS) images of coronary arteries in 33 heart transplant recipients. Coronary microvascular disease was classified by light microscopy into four grades based on thickening of endothelial cell layer and stenotic versus nonstenotic medial wall thickening. Macrovascular disease was evaluated from IVUS studies and assigned into one of five grades based on the Stanford classification. Coronary microvascular and macrovascular diseases were compared. Results. Age at transplantation was 26 (18) years; 67% were men, and the average time to posttransplantation study was 4 years. Endomyocardial biopsy revealed more advanced grade C and D microvascular disease in 45% and 36% of the patients, respectively. However, IVUS analysis for macrovascular disease revealed mostly lesser changes with grade 1 in 12%, grade 2 in 61%, and grade 3 in 21%. There was no significant correlation between grades of microvascular and macrovascular disease (P=0.10). Microvascular disease correlated positively with donor age (P=0.06) and treatment with tacrolimus (0=0.02) and statins (P=0.05). Conclusions. There is a poor relationship between coronary microvascular and macrovascular disease in patients with cardiac transplants, likely indicating divergent pathogenetic mechanisms. Microvascular disease increases with donor age. There is an intriguing positive relationship between microvascular disease and treatment with statins and tacrolimus.
引用
收藏
页码:965 / 970
页数:6
相关论文
共 15 条
[1]  
ARAI S, 1992, J HEART LUNG TRANSPL, V11, P757
[2]   Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy-Results of a Randomized, Multicenter Trial [J].
Arora, Satish ;
Ueland, Thor ;
Wennerblom, Bertil ;
Sigurdadottir, Vilborg ;
Eiskjaer, Hans ;
Botker, Hans E. ;
Ekmehag, Bjorn ;
Jansson, Kjell ;
Mortensen, Svend-Aage ;
Saunamaki, Kari ;
Simonsen, Svein ;
Gude, Einar ;
Bendz, Bjorn ;
Solbu, Dag ;
Aukrust, Pal ;
Gullestad, Lars .
TRANSPLANTATION, 2011, 92 (02) :235-243
[3]   Non-Atheroprotective Effects of Statins A Systematic Review [J].
Beri, Abhimanyu ;
Sural, Neethi ;
Mahajan, Snigdha B. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (06) :361-370
[4]   LONG-TERM FOLLOW-UP AFTER ORTHOTOPIC HEART-TRANSPLANTATION [J].
HEUBLEIN, B ;
HAVERICH, A ;
BORST, HG .
THORACIC AND CARDIOVASCULAR SURGEON, 1990, 38 (05) :285-290
[5]   Prognostic impact of microvasculopathy on survival after heart transplantation - Evidence from 9713 Endomyocardial biopsies [J].
Hiemann, Nicola E. ;
Wellnhofer, Ernst ;
Knosalla, Christoph ;
Lehmkuhl, Hans B. ;
Stein, Julia ;
Hetzer, Roland ;
Meyer, Rudolf .
CIRCULATION, 2007, 116 (11) :1274-1282
[6]   Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy [J].
Klauss, V ;
König, A ;
Spes, C ;
Meiser, B ;
Rieber, J ;
Siebert, U ;
Regar, E ;
Pfeiffer, M ;
Reichart, B ;
Theisen, K ;
Mudra, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (02) :266-269
[7]  
MEHRA MR, 1995, J HEART LUNG TRANSPL, V14, P632
[8]   EFFECTS OF CYCLOSPORINE, FK506, AND RAPAMYCIN ON GRAFT-VESSEL DISEASE [J].
MEISER, BM ;
BILLINGHAM, ME ;
MORRIS, RE .
LANCET, 1991, 338 (8778) :1297-1298
[9]   Tacrolimus or cyclosporine:: Which is the better partner for mycophenolate-mofetil in heart transplant recipients? [J].
Meiser, BM ;
Groetzner, J ;
Kaczmarek, I ;
Landwehr, P ;
Müller, M ;
Jung, S ;
Überfuhr, P ;
Fraunberger, P ;
Stempfle, HU ;
Weis, M ;
Reichart, B .
TRANSPLANTATION, 2004, 78 (04) :591-598
[10]   HEART GRAFT ARTERIOSCLEROSIS - AN OMINOUS FINDING ON ENDOMYOCARDIAL BIOPSY [J].
PALMER, DC ;
TSAI, CC ;
ROODMAN, ST ;
CODD, JE ;
MILLER, LW ;
SARAFIAN, JE ;
WILLIAMS, GA .
TRANSPLANTATION, 1985, 39 (04) :385-388